McManus, H. D. & Armstrong, A. J. The past, present, and future of treatment intensification for metastatic hormone-sensitive prostate cancer. J. Clin. Oncol. 41, 3576–3579 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beyer, K. et al. How can we improve patient-clinician communication for men diagnosed with prostate cancer? Eur. Urol. Open Sci. 62, 1–7 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Oswald, L. B. et al. What do men with metastatic prostate cancer consider when making treatment decisions? A mixed-methods study. Patient Prefer. Adherence 14, 1949–1959 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Wittmann, D. et al. Guidelines for sexual health care for prostate cancer patients: recommendations of an international panel. J. Sex. Med. 19, 1655–1669 (2022).

Article  PubMed  Google Scholar 

Markowski, M. C. et al. PSA doubling time and absolute PSA predict metastasis-free survival in men with biochemically recurrent prostate cancer after radical prostatectomy. Clin. Genitourin. Cancer 17, 470–475.e1 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Ost, P. et al. Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial. J. Clin. Oncol. 36, 446–453 (2018).

Article  CAS  PubMed  Google Scholar 

Phillips, R. et al. Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial. JAMA Oncol. 6, 650–659 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Freedland, S. J. et al. Improved outcomes with enzalutamide in biochemically recurrent prostate cancer. N. Engl. J. Med. 389, 1453–1465 (2023).

Article  CAS  PubMed  Google Scholar 

Freedland, S. J. et al. Effects of enzalutamide on the sexual activity of patients with biochemically recurrent prostate cancer: a post hoc analysis of patient-reported outcomes in the EMBARK study. Eur. Urol. 87, 507–511 (2025).

Article  CAS  PubMed  Google Scholar 

Chodak, G. et al. Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma. Urology 46, 849–855 (1995).

Article  CAS  PubMed  Google Scholar